Company Filing History:
5 out of 22 
1 out of 1 
1 out of 8 Years Active: 2016-2023
Title: The Innovative Mind of Athurva Gore
Introduction
Athurva Gore, a distinguished inventor based in Cambridge, MA, holds an impressive portfolio of seven patents. His innovations primarily focus on advancements in genetic screening and nucleic acid analysis, showcasing his commitment to enhancing our understanding of genomics and biotechnology.
Latest Patents
Athurva's latest patents include groundbreaking methods that significantly impact the field of genetic research. One notable invention is titled "Screening for Structural Variants." This method relates to carrier screening and utilizes probes designed to identify structural variants within an individual's genome. By revealing substitution mutations and small structural variants, his work contributes to a deeper understanding of chromosomal abnormalities. This methodology involves exposing nucleic acids to several probes, which are engineered to hybridize around specific targets within the genome, thereby allowing for the detection of significant genetic information.
Another pivotal patent is "Methods for Selectively Suppressing Non-Target Sequences." This invention addresses the challenge of separating a target gene or region of interest from unwanted nucleic acid segments. By employing complementary nucleic acid to create double-stranded regions, unwanted sequences can be digested away. This innovative approach enhances the analysis of critical genetic information, removing interference from similar genomic elements, including paralogs and pseudogenes.
Career Highlights
Athurva Gore's professional journey includes significant roles at reputable companies, including Good Start Genetics, Inc. and Molecular Loop Biosciences, Inc. His work at these organizations further emphasizes his expertise in genomics and biotechnology, allowing him to apply and develop his innovative concepts effectively.
Collaborations
Throughout his career, Athurva has collaborated with esteemed professionals in the field, notably Mark Umbarger and Gregory J Porreca. These partnerships have contributed to the enriched development and validation of his inventions, demonstrating the value of collaboration in driving innovative research.
Conclusion
Athurva Gore's contributions to the field of biotechnology through his seven patents exemplify the spirit of innovation. His focus on structural variant screening and the selective suppression of non-target sequences has the potential to transform genetic analysis, significantly impacting public health and research. As he continues to explore new frontiers in this evolving field, Athurva's work is undoubtedly paving the way for future advancements in genomics.